Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?

James R Clem1 South Dakota State University College of Pharmacy Sioux Falls, South Dakota, USACorrespondence[email protected]

Joe D Strain2 South Dakota State University College of Pharmacy, Rapid City Regional Hospital, Rapid City, South Dakota, USA

Debra K Farver3 South Dakota State University College of Pharmacy, Yankton, South Dakota, USA

Pages 1-11 | Published online: 22 Dec 2009

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

World Health OrganizationCardiovascular disease fact sheet2007 URL: http://www.who.int/mediacentre/factsheets/fs317/en/index.htmlAccessed Sept 23, 2009
Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA20012852486249711368702
PubMed Web of Science ®Google Scholar
De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice [Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice]Eur Heart J2003241601161012964575
PubMed Web of Science ®Google Scholar
GrundySMCleemanJIMerzCNImplications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation200411022723915249516
PubMed Web of Science ®Google Scholar
SmithSCJrAllenJBlairSNAHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 UpdateJ Am Coll Cardiol2006472130213916697342
PubMed Web of Science ®Google Scholar
Executive Summary: Standards of Medical Care in Diabetes – 2009Diabetes Care200932Suppl 1s6s1219118288
PubMed Web of Science ®Google Scholar
JonesPHMcKenneyJMKaralisDGDowneyJComparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemiaAm Heart J2005149e1e815660024
PubMed Web of Science ®Google Scholar
JonesPKafonekSLauroraIHunninghakeDComparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The CURVES Study)Am J Cardiol1998815825879514454
PubMed Web of Science ®Google Scholar
EUROASPIRE I and II GroupClinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countriesLancet2001357995100111293642
PubMed Web of Science ®Google Scholar
HermansMPVan MieghemWVandenhovenGVissersECentralized Pan-European Survey on the Undertreatment of Hypercholesterolaemia (CEPHEUS)Acta Cardiol20096417718519476109
PubMed Web of Science ®Google Scholar
LevineAPMikhailidisDPMorossTBensonKGorMAchieving Vascular risk factor targets: a survey of a London general practiceAngiology200859364618319220
PubMed Web of Science ®Google Scholar
British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke AssociationJBS 2: Joint British Societies’ Guidelines on Prevention of Cardiovascular Disease in Clinical PracticeHeart200591suppl vv1v5216365341
PubMed Web of Science ®Google Scholar
CannonCPBraunwaldEMcCabeCHIntensive versus moderate lipid lowering with statins after acute coronary syndromesN Engl J Med20043501495150415007110
PubMed Web of Science ®Google Scholar
Cholesterol Treatment Trialists’ CollaboratorsEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statinsLancet200536612677816214597
PubMed Web of Science ®Google Scholar
Lipitor (atrovastatin calcium) Prescribing InformationPfizer Inc62009 URL: http://www.pfizer.com/files/products/uspi_lipitor.pdfAccessed Sept 24, 2009
Google Scholar
McKenneyJMDavidsonMHSaponaroJUse of a treatment algorithm to achieve NCEP ATP III goals with atorvastatinJ Cardiovasc Pharmacol20054659459916220065
PubMed Web of Science ®Google Scholar
MartineauPGawAde TeresaEEffect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: The Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-1) studyAtherosclerosis200719113514616643923
PubMed Web of Science ®Google Scholar
FarsangCAthyrosVGawAA multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) studyCurr Med Res Opin2007231945195617626713
PubMed Web of Science ®Google Scholar
DucobuJClaeysMCommersKEfficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose studyCurr Med Res Opin2007231821182717609019
PubMed Web of Science ®Google Scholar
Atorvastatin Study Group in KoreaFlexible initial dosing of atorvastatin based upon initial lo-density lipoprotein cholesterol levels in type 2 diabetic patientsKorean J Intern Med200823222918363276
PubMedGoogle Scholar
Ferrer-GarciaJCSnachez-BallesterEAlbalat-GaleraREfficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetesJ Cardiovasc Pharmacol Ther20081318318818635754
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date